Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
TGTX
— TG Therapeutics, Inc.
NASDAQ
FULL STOCK PAGE →
Q4 2025 Earnings Call Summary
FEB 26, 2026
REVENUE
$192.6M
+19.1%
NET MARGIN
12.0%
-229.8 PTS
EPS
$0.16
-94.1%
FREE CASH FLOW
$19.6M
+184.3%
No summary has been written for this call yet.
← NEWER CALL
CALL 3 OF 4
OLDER CALL →